1,2-dipalmitoylphosphatidylcholine has been researched along with Inflammation in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henrich, SE; Hong, BJ; Nguyen, ST; Rink, JS; Thaxton, CS | 1 |
Casey, A; Chambers, G; Murphy, A; Sheehy, K | 1 |
Abate, W; Alghaithy, AA; Jackson, SK; Jones, KP; Parton, J | 1 |
Bao, S; Barter, PJ; Bursill, C; Di Bartolo, BA; Heather, AK; Nicholls, SJ; Rye, KA | 1 |
Bao, S; Barter, PJ; Bursill, CA; Di Bartolo, BA; Rye, KA; Tan, JT; Vanags, LZ | 1 |
Dial, EJ; Illich, PA; Lichtenberger, LM; Romero, JJ; Ulloa, C; Vanous, AL; Walters, ET | 1 |
Frokjaer, S; Jørgensen, K; Schiffelers, R; Vermehren, C | 1 |
Jackson, SK; Jones, KP; Morris, RH; Price, AJ; Thomas, AW; Tonks, A | 1 |
Anthony, DC; Kinney, RC; Kohane, DS; Langer, R; Lipp, M; Lotan, N; Louis, DN | 1 |
9 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Inflammation
Article | Year |
---|---|
Supramolecular Assembly of High-Density Lipoprotein Mimetic Nanoparticles Using Lipid-Conjugated Core Scaffolds.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biomimetic Materials; Cholesterol; DNA; Drug Carriers; Gold; Hep G2 Cells; Humans; Inflammation; Lipoproteins, HDL; Liposomes; Metal Nanoparticles; Monocytes; NF-kappa B p50 Subunit; Phosphatidylethanolamines | 2019 |
The surfactant dipalmitoylphophatidylcholine modifies acute responses in alveolar carcinoma cells in response to low-dose silver nanoparticle exposure.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenocarcinoma, Bronchiolo-Alveolar; Cell Line, Tumor; Cell Survival; Coloring Agents; Humans; Inflammation; Lung Neoplasms; Metal Nanoparticles; Oxazines; Reactive Oxygen Species; Silver; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay; Xanthenes | 2015 |
Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Cell Line; Cell Survival; Down-Regulation; Epithelial Cells; Humans; Inflammation; Interleukin-8; Lipopolysaccharides; Lung; Membrane Microdomains; Phospholipids; Protein Transport; Pulmonary Surfactants; Toll-Like Receptor 4 | 2010 |
The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Inflammatory Agents; Apolipoprotein A-I; Carotid Artery Diseases; Chemokine CCL2; Chemokine CX3CL1; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Inflammation; Infusions, Intravenous; Intercellular Adhesion Molecule-1; Intercellular Signaling Peptides and Proteins; Lipoproteins; Lipoproteins, HDL; Molecular Mimicry; Monocytes; Peptides; Rabbits; RNA, Messenger; Signal Transduction; Sphingomyelins; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2011 |
The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Apolipoprotein A-I; Cells, Cultured; Cholesterol; Chronic Disease; Endothelial Cells; Gene Expression; Humans; Inflammation; Intercellular Adhesion Molecule-1; Lipoproteins, HDL; Male; Peptides; Rabbits; Random Allocation; Sphingomyelins; Transcription Factor RelA; Vascular Cell Adhesion Molecule-1 | 2011 |
Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Analysis of Variance; Animals; Aspirin; Body Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Male; Pain; Rats; Rats, Sprague-Dawley | 1996 |
Activity of mammalian secreted phospholipase A(2) from inflammatory peritoneal fluid towards PEG-liposomes. Early indications.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Ascitic Fluid; Caseins; Drug Carriers; Inflammation; Liposomes; Phospholipases A; Polyethylene Glycols; Rats | 2001 |
Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinases.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Cell Line; Humans; Inflammation; Luminescent Measurements; MAP Kinase Signaling System; Membrane Lipids; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Monocytes; p38 Mitogen-Activated Protein Kinases; Phospholipids; Phosphorylation; Protein Processing, Post-Translational; Pulmonary Surfactants; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan | 2001 |
Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anesthetics, Local; Animals; Biocompatible Materials; Bupivacaine; Delayed-Action Preparations; Drug Delivery Systems; Inflammation; Lactic Acid; Lactose; Male; Microspheres; Nerve Block; Peripheral Nerves; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Serum Albumin; Time Factors | 2002 |